Just 5 minutes of prayer could have surprising health benefits, study finds

A new study published in The Annals of Family Medicine found that adult patients experienced significant pain and anxiety ...
Morning Overview on MSN

A daily multivitamin slowed all five epigenetic aging clocks in a randomized trial — people who started biologically older saw the biggest benefit

A standard daily multivitamin, the kind sold at every pharmacy for roughly a dime a dose, slowed biological aging across ...

Study reveals unexpected health benefits after 5 minutes of prayer

Adult patients experienced significant relief from pain and anxiety after just five minutes of in-person prayer, as found in ...
Morning Overview on MSN

A 3 mg melatonin pill before daytime sleep just boosted night shift workers’ DNA repair by 80% — the first trial built to test the link

Roughly 15 million Americans clock in for night shifts, and the World Health Organization’s cancer research arm has ...

Invivyd Announces Completion of Enrollment in Upsized DECLARATION Clinical Trial, a Phase 3 Pivotal Study of VYD2311, an Investigational Antibody to Prevent COVID

DECLARATION is a Phase 3, randomized, placebo-controlled clinical trial to evaluate the safety and efficacy of VYD2311 in the prevention of ...

Tiger BioSciences Announces Publication of Interim TIGERCAMP Randomized Controlled Trial Data Demonstrating caregraFT™ Plus Standard of Care Outperform…

Tiger BioSciences announced the publication of interim data from the ongoing TIGERCAMP randomized controlled trial (RCT), now ...
ascopubs.org

A multicenter, randomized, controlled, open-label trial to determine the optimal duration of steroid therapy for mild pneumonitis associated with immune checkpoint inhibitors.

Results of a multisite randomized trial of Bright IDEAS-Young Adults: Efficacy of problem-solving skills training on distress and health-related quality of life. This is an ASCO Meeting Abstract from ...
ascopubs.org

Clinical outcomes of the DIET study: A randomized controlled phase 2 trial of a high fiber diet intervention (HFDI) in patients with melanoma receiving immune checkpoint ...

A phase II study of the interleukin-6 (IL-6) receptor blocking antibody sarilumab (Sari) in combination with ipilimumab (Ipi), nivolumab (Nivo) and relatlimab (Rela) in patients with unresectable ...